Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis

This study has been completed.

Study NCT00004744 Information provided by Office of Rare Diseases (ORD)

First Received: February 24, 2000 Last Updated: September 8, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	September 1998 (Final data collection date for primary outcome measure)